Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
priority review
Pharma
Novartis complies with FDA 'flexibility' ask in Pluvicto filing
Novartis didn't use a priority review voucher for Pluvicto's new application upon a request from the FDA, CEO Vas Narasimhan explained.
Angus Liu
Oct 29, 2024 10:51am
FDA speeds Sanofi, Regeneron's application for Dupixent in COPD
Feb 22, 2024 11:25pm
Sarepta's Elevidys expansion bid gets fast review without adcomm
Feb 16, 2024 11:05am
Takeda's dengue vaccine gets moved up in the FDA review queue
Nov 23, 2022 10:30am
Seagen's Tukysa picks up FDA priority review in Herceptin combo
Sep 20, 2022 10:59am
Evrysdi nabs speedy review in SMA patients younger than 2 months
Jan 25, 2022 10:00am
